Impunity Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 2022.
2022 Indore, Madhya Pradesh, India Active
Last Updated:
About Impunity Pharma Private Limited

Impunity Pharma Private Limited, a active private limited company, was established on 27 July 2022 in Indore, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232MP2022PTC062016. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ram Sewak Batham (Director), Ashish Batham (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Subhash Ramjimlal Gupta, Colony Gandhi Gram Hat Maidan A.B Road Mangliya, Indore, Madhya Pradesh, 453771.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2022PTC062016

  • Registration Number

    062016

  • Incorporation Date

    27 July 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Impunity Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Impunity Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Impunity Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ram Sewak Batham Director 27 Jul 2022 Current
Ashish Batham Director 27 Jul 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Impunity Pharma.

Enhance accessibility to Impunity Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Impunity Pharma revenue growth over time
Impunity Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Impunity Pharma?

Unlock access to Impunity Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Impunity Pharma?

Impunity Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Impunity Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impunity Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Impunity Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Impunity Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Impunity Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.

  • Director Appointment

    Progress on Ram Sewak Batham was appointed as a Director was appointed as a Director on 27 Jul 2022 & has been associated with this company since 3 years 8 months . was documented.

  • Director Appointment

    The activity Ashish Batham was appointed as a Director was appointed as a Director on 27 Jul 2022 & has been associated with this company since 3 years 8 months . was completed.

  • Company Incorporation

    Progress on Impunity Pharma Private Limited was registered on 27 Jul 2022 with Roc Gwalior & aged 3 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Impunity Pharma Private Limited?

The CIN of Impunity Pharma Private Limited is U24232MP2022PTC062016.

Where is Impunity Pharma Private Limited headquartered?

Impunity Pharma Private Limited is headquartered at C/O Subhash Ramjimlal Gupta, Colony Gandhi Gram Hat Maidan A.B Road Mangliya, Indore, Madhya Pradesh, 453771.

When was Impunity Pharma Private Limited incorporated?

Impunity Pharma Private Limited was incorporated on 27 July 2022.

Who are the current directors of Impunity Pharma Private Limited?

The current directors of Impunity Pharma Private Limited are

What is the primary industry of Impunity Pharma Private Limited?

The primary industry of Impunity Pharma Private Limited is Chemicals.

Is Impunity Pharma Private Limited a listed company?

Impunity Pharma Private Limited is unlisted.

What is the capital structure of Impunity Pharma Private Limited?

The authorized capital of Impunity Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available